On August 16, JD Health released its 2023 interim performance announcement. During the reporting period, JD Health’s total revenue was RMB 27.1 billion, a year-on-year increase of 34%, and the non-IFRS net profit was 2.44 billion yuan, a year-on-year increase of 101.2%; as of June 30, 2023, The trailing 12-month annual active user count was approximately 169 million, representing a net increase of 37.3 million annual active user count as of June 30, 2022.
The announcement shows that in the first half of the year, JD Health continued to strengthen the construction of the omni-channel medical and health supply chain, and continued to improve the online and offline integrated medical and health retail layout with JD Pharmacy as the core; at the same time, JD Health continued to create more professional for users. Service experience, join hands with global pharmaceutical and health companies to promote the digital transformation of the industry and the upgrade of service experience.
Accelerate the implementation of the capabilities of the pharmaceutical supply chain and consolidate the advantages of the "first stop" for the online launch of new drugs
The announcement shows that in the first half of 2023, JD Health will continue to improve the construction of the pharmaceutical supply chain, continue to deepen cooperation with many global pharmaceutical and health companies, and continuously improve the supply capacity of all categories. At present, JD Health has become the preferred partner of more and more medical and health enterprises to develop omni-channel.
During the reporting period, a number of drugs including Ruifu® (upatinib sustained-release tablet), a targeted innovative drug for atopic dermatitis, Fubangde® (enomitinib tablet), a new anti-AIDS drug, and Rilupine®, a new diabetes drug The new drug was launched online in Jingdong Pharmacy. At the same time, JD Health has also implemented a reverse customization model for new products with Tongrentang, Jianhe Group, BY-HEALTH and many other well-known nutrition and health brands. Through its advantages in health consumption data precipitation, crowd analysis, and category insights, it provides them with integrated data. A solution integrating intelligent transformation, brand marketing and channel expansion.
During the reporting period, JD Health's omni-channel layout has covered more than 400 cities across the country, with more than 1,200 cooperative chain brands and more than 100,000 cooperative stores, of which the number of cooperative stores located in third-tier cities and below accounted for more than 60%. JD Health also continues to promote the online and offline integration of service formats through the layout of offline DTP pharmacies (Direct to Patient, that is, pharmacies that provide professional services directly to patients), and accelerate the improvement of professional service capabilities covering all categories. At present, JD Pharmacy’s DTP pharmacy stores have covered 26 provinces and cities across the country, operating more than 400 special drug varieties, and have become an important choice for many innovative pharmaceutical companies to develop omni-channel.
In the first half of 2023, the number of new merchants in JD Health’s open ecosystem will expand rapidly. Currently, JD Health’s online platform has more than 36,000 third-party merchants. By providing a more complete operation support system and digital marketing strategy, JD Health can reduce the operating costs of merchants, improve the operating efficiency of merchants, and help merchants achieve growth. During the 618 period this year, the number of products participating in promotional activities increased to a new high year-on-year, and the turnover of more than 7,000 merchants doubled year-on-year.
Deepen professional service capabilities and build better drug retail services
In the first half of 2023, relying on the "Single Disease Care Center" and "Pharmaceutical Clinic", JD Health will continue to improve the professional service experience, and provide professional pharmaceutical services for patients in the whole process of drug purchase, medication and repurchase, and provide one-stop solutions Patient safety medication issues. At the same time, relying on JD Health Internet Hospital, the first professional online diagnosis and treatment portal in China, JD Health has created a more professional, convenient and safer medical consumption experience for users.
It is noteworthy that in the first half of the year, JD Health Internet Hospital used innovative technology and digital operation capabilities to further optimize the user experience of medical service products, and continued to create a safe, reliable, and user-trusted online diagnosis and treatment first entrance. In the first half of the year, more than 440,000 Users provide online consultation services.
While providing users with a wide range of products, JD Health creates differentiated service advantages of "good" products and "good" experience. Among them, JD Health's O2O drug purchase service "JD Drug Express" can provide users with door-to-door drug purchase services covering all hours. Based on this, JD Health already has the most complete online and offline integrated retail layout in the industry through the complementary advantages of "B2C+O2O+DTP stores".
At present, JD Health has achieved nationwide indiscriminate access to medical and health services. In the future, JD Health will further promote the open ecological strategy, continuously improve the medical and health supply chain and the construction of medical and health service capabilities, and is committed to providing users with easy-to-obtain, convenient and affordable services. affordable healthcare products and services.